BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2157 related articles for article (PubMed ID: 22621238)

  • 1. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
    Miao Z; Ren G; Liu H; Jiang L; Cheng Z
    J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
    Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
    Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
    Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
    Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
    Qi S; Hoppmann S; Xu Y; Cheng Z
    Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors.
    Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z
    Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro evaluation of Cy5.5 conjugated epidermal growth factor receptor binding peptide.
    Jeong MH; Kim K; Kim EM; Cheong SJ; Lee CM; Jeong HJ; Kim DW; Lim ST; Sohn MH; Chung J
    Nucl Med Biol; 2012 Aug; 39(6):805-12. PubMed ID: 22421431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.
    Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS
    Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide.
    Li G; Xing Y; Wang J; Conti PS; Chen K
    Amino Acids; 2014 Jun; 46(6):1547-56. PubMed ID: 24652439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
    Miao Z; Ren G; Liu H; Jiang L; Cheng Z
    Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator.
    Andersson KG; Oroujeni M; Garousi J; Mitran B; Ståhl S; Orlova A; Löfblom J; Tolmachev V
    Int J Oncol; 2016 Dec; 49(6):2285-2293. PubMed ID: 27748899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
    Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
    Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical imaging of articular cartilage degeneration using near-infrared dipicolylamine probes.
    Hu X; Wang Q; Liu Y; Liu H; Qin C; Cheng K; Robinson W; Gray BD; Pak KY; Yu A; Cheng Z
    Biomaterials; 2014 Aug; 35(26):7511-21. PubMed ID: 24912814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
    Friedman M; Orlova A; Johansson E; Eriksson TL; Höidén-Guthenberg I; Tolmachev V; Nilsson FY; Ståhl S
    J Mol Biol; 2008 Mar; 376(5):1388-402. PubMed ID: 18207161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorogen activating protein-affibody probes: modular, no-wash measurement of epidermal growth factor receptors.
    Wang Y; Telmer CA; Schmidt BF; Franke JD; Ort S; Arndt-Jovin DJ; Bruchez MP
    Bioconjug Chem; 2015 Jan; 26(1):137-44. PubMed ID: 25490520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules.
    Garousi J; Andersson KG; Mitran B; Pichl ML; Ståhl S; Orlova A; Löfblom J; Tolmachev V
    Int J Oncol; 2016 Apr; 48(4):1325-32. PubMed ID: 26847636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Characterization, and Biomedical Applications of a Targeted Dual-Modal Near-Infrared-II Fluorescence and Photoacoustic Imaging Nanoprobe.
    Cheng K; Chen H; Jenkins CH; Zhang G; Zhao W; Zhang Z; Han F; Fung J; Yang M; Jiang Y; Xing L; Cheng Z
    ACS Nano; 2017 Dec; 11(12):12276-12291. PubMed ID: 29202225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo fluorescence imaging for cancer diagnosis using receptor-targeted epidermal growth factor-based nanoprobe.
    Ryu JH; Shin M; Kim SA; Lee S; Kim H; Koo H; Kim BS; Song HK; Kim SH; Choi K; Kwon IC; Jeon H; Kim K
    Biomaterials; 2013 Dec; 34(36):9149-59. PubMed ID: 23998858
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 108.